What is the recommended dosing of Antivenom Serum (ASV) for neurotoxic and vasculotoxic snake bites in India?

ASV Dosing for Neurotoxic and Vasculotoxic Snake Bites in India

Initial Dosing Recommendation

For neurotoxic envenomation, administer an initial dose of 10 vials of polyvalent ASV, while for vasculotoxic (hemotoxic) envenomation, start with 10 vials followed by repeat dosing based on 20-minute Whole Blood Clotting Time (20WBCT) normalization. 1, 2

Neurotoxic Envenomation (Krait, Cobra)

Initial Management

• Administer 10 vials of Indian polyvalent ASV as the initial dose 1
• This high initial dose offers practical advantages as a single administration without increasing total consumption or adverse reaction risk compared to lower doses 1
• The 2-vial initial regimen is inadequate and shows no difference in outcomes compared to 10 vials, making the higher dose preferable for simplicity 1

Subsequent Dosing

• Perform hourly neurological assessments following initial antivenom administration 1
• Neurotoxic signs respond slowly and unconvincingly to ASV 3
• Continuous absorption of venom may cause recurrent neurotoxicity, requiring additional ASV doses 3
• Some cases require very high cumulative doses (up to 40 vials have been documented) for reversal of neurological manifestations 3, 4
• Continue close observation and ASV administration until neurological improvement is sustained 3

Critical Considerations

• Krait bites typically require higher total ASV doses and have worse outcomes than cobra bites 1
• Currently available Indian polyvalent ASV performs poorly for neurotoxic envenomation, with 43.5% of patients experiencing death, requiring assisted ventilation, or developing worsening/recurrent neurotoxicity despite treatment 1

Vasculotoxic (Hemotoxic) Envenomation (Viper)

Initial Dosing Protocol

• Administer 10 vials (100 ml) of ASV as initial dose 2
• Follow with 10 vials every 6 hours until 20WBCT normalizes 2
• Maximum initial protocol: 30 vials (300 ml) total if 20WBCT remains positive 2

Alternative Lower-Dose Protocol

• Initial 7 vials (70 ml) followed by 3 vials (30 ml) every 6 hours until two consecutive 20WBCT tests are negative 2
• This lower-dose protocol shows no statistical difference in mortality, morbidity, or total ASV consumption compared to the higher-dose national protocol 2

Monitoring and Repeat Dosing

• Check 20WBCT at 6-hour intervals after each ASV dose 2
• Continue ASV administration until 20WBCT normalizes 2
• Average total dose required is 7.5 vials (range 2-40 vials, median 6 vials) 4

Adjunctive Therapy for Venom-Induced Consumption Coagulopathy (VICC)

• Consider Fresh Frozen Plasma (FFP) administration in addition to ASV for patients with VICC 5
• Combined ASV plus FFP shows better outcomes in terms of recovery time, reduced renal complications, and lower mortality compared to ASV alone 5
• FFP addresses irreversible clotting factor deficiencies that ASV cannot reverse once damage has occurred 5

Critical Timing Considerations

• Administer ASV within the first 4 hours of envenomation whenever possible 5
• Complications from snake bite are minimized when ASV is given within this window 5
• Early administration is crucial because antivenom cannot reverse irreversible toxic effects once tissue damage has occurred 5

Important Pitfalls to Avoid

Dosing Errors

• Do not assume a uniform low dose (2-6 vials) will be sufficient for all cases 3, 1
• In 12% of hemotoxic cases, clotting time remains persistently prolonged despite ASV administration until death, indicating severe envenomation 2
• No relapse of clotting abnormalities occurs once normalized, so do not continue ASV beyond normalization of 20WBCT 2

Monitoring Failures

• Failure to perform serial 20WBCT testing every 6 hours in vasculotoxic envenomation leads to inadequate dosing decisions 2
• Inadequate observation for recurrent neurotoxicity after initial improvement is dangerous, as continuous venom absorption can cause relapse 3

Protocol Inconsistencies

• Current practice in India shows significant variation from the National Snakebite Management Protocol, with no uniform dosing approach followed 4
• The Indian National Protocol (10 vials initially, then 10 vials every 6 hours up to 30 vials maximum) does not demonstrate superiority over lower-dose protocols in reducing mortality or morbidity 2

Practical Algorithm

For Neurotoxic Bites:

1. Give 10 vials ASV immediately 1
2. Assess neurological status hourly 1
3. Administer additional vials if neurotoxicity persists or recurs 3
4. Continue until sustained neurological improvement 3

For Vasculotoxic Bites:

1. Give 10 vials ASV immediately 2
2. Check 20WBCT at 6 hours 2
3. If positive, give another 10 vials 2
4. Repeat steps 2-3 until 20WBCT normalizes (maximum 30 vials in initial protocol) 2
5. Consider FFP for VICC 5

Page: 1

Last printed: 12/32/2024 8:24:00 PM